Eli Lilly Financial Statements
Eli Lilly Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Eli Lilly Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 18,633.5 | 15,691.0 | 14,645.3 |
| Gross Profit ($ mil.) | 14,384.7 | 12,144.5 | 11,171.1 |
| Operating Income ($ mil.) | 3,754.8 | 3,180.2 | 2,403.3 |
| Total Net Income ($ mil.) | 2,953.0 | 2,662.7 | 1,979.6 |
| Diluted EPS (Net Income) | 2.71 | 2.45 | 1.81 |
Eli Lilly Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 4,807.6 | 5,189.6 | 4,586.8 |
| Gross Profit ($ mil.) | 3,696.3 | 3,916.8 | 3,532.2 |
| Operating Income ($ mil.) | 1,036.0 | 1,020.2 | 1,128.6 |
| Total Net Income ($ mil.) | 1,064.3 | 854.4 | 926.3 |
| Diluted EPS (Net Income) | 0.97 | 0.78 | 0.85 |
Eli Lilly Stock Quote & Chart
07/18/08 15:01:42 EST •
NYSE •
47.91
•
 -0.4700
•
-0.9715 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Eli Lilly Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.82 | 3.83 | 1.53 |
| Price/Earnings Ratio | 14.85 | 16.05 | 15.13 |
| Price/Book Ratio | 3.64 | 2.77 | 1.47 |
| Price/Cash Flow Ratio | 9.09 | 11.65 | 9.51 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Eli Lilly Financial Ratios
Eli Lilly Competitive Intelligence
| GlaxoSmithKline | Novo Nordisk | Pfizer | |
|---|---|---|---|
| Annual Sales ($ mil.) | 45,816.1 | 8,261.6 | 48,418.0 |
| Employees | -- | 26,000 | 86,600 |
| Market Cap ($ mil.) | -- | -- | 123,532.5 |
Competitive Landscape
